| 000 | 01141 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515011832.0 | ||
| 264 | 0 | _c20060504 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/kei234 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSomerville, M | |
| 245 | 0 | 0 |
_aMaximizing the use of scarce resources: vial optimization. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cMar 2006 |
||
| 300 |
_a353-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xeconomics |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xeconomics |
| 650 | 0 | 4 |
_aCost Control _xmethods |
| 650 | 0 | 4 |
_aDrug Costs _xstatistics & numerical data |
| 650 | 0 | 4 | _aEngland |
| 650 | 0 | 4 | _aHealth Resources |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aRheumatic Diseases _xdrug therapy |
| 700 | 1 | _aBrooksby, A | |
| 700 | 1 | _aScott, D G I | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 45 _gno. 3 _gp. 353-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kei234 _zAvailable from publisher's website |
| 999 |
_c15996249 _d15996249 |
||